Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice

被引:67
作者
Mirahmadi, N. [1 ]
Babaei, M. H. [2 ]
Vali, A. M. [3 ]
Dadashzadeh, S. [1 ,4 ]
机构
[1] Shahid Beheshti Univ, Sch Pharm, Dept Pharmaceut, Tehran, Iran
[2] Atom Energy Org Iran, Nucl Res Ctr, Radioisotope Div, Tehran, Iran
[3] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Zanjan, Iran
[4] Shahid Beheshti Univ, Pharmaceut Sci Res Ctr, Tehran, Iran
关键词
Liposomes; Size; (99m)Tc-HMPAO; Peritoneal retention; Peritoneal carcinomatosis; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; PEGYLATED LIPOSOMES; OVARIAN-CANCER; DRUG-DELIVERY; IN-VITRO; CHEMOTHERAPY; MODEL; AGENTS; PHARMACOKINETICS;
D O I
10.1016/j.ijpharm.2009.08.034
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Peritoneal carcinomatosis is a serious concern when treating digestive or ovarian tumors. Treatment with systemic chemotherapy suffers from poor penetration of cytotoxic agents into the peritoneal cavity and is not quite effective. Local delivery of drugs, especially as controlled-release delivery systems like liposomes, could provide sustained and higher drug levels and reduce systemic toxicity. In order to investigate the effect of liposome size on peritoneal retention, liposomes composed of distearoylphosphatidylcholine and cholesterol (DSPC/CHOL, molar ratio 2:1) were prepared at four sizes of 100, 400, 1000 and 3000 nm. Subsequently, these liposomes were labeled with (99m)Tc complex of hexamethylpropyleneamineoxime ((99m)Tc-HMPAO) and injected into mouse peritoneum. Then, mice were sacrificed at eight different time points and the percentage of injected radiolabel in the peritoneal cavity and the organ distribution in terms of percentage injected dose/gram tissue (%1D/g) were obtained. Results showed that the free label ((99m)Tc-HMPAO) was cleared very rapidly from the cavity so that after 5 min and 7 h only 6.89 +/- 2.51% and 0.91 +/- 0.51% of the injected dose was recovered, respectively. However, for the liposomal formulations, this recovery value ranged from 8.47 +/- 1.62% to 29.99 +/- 12.06% at 7 h. Peritoneal retention of the vesicles was increased with their size, and the highest retention rate was obtained with 1000 nm liposomes with an AUC value 15.51 times that of (99m)Tc-HMPAO. In blood, as expected. 100 nm liposomes showed much higher levels because of their greater stability. Their greater blood concentration also caused increased levels in the heart and kidneys, although their organ to blood AUC ratio was the lowest. Overall, among the different sized neutral liposomes investigated, the 1000 nm vesicles seemed to be the most optimal, achieving a greater peritoneal level and retention. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 36 条
[1]
SUBCUTANEOUS ADMINISTRATION OF LIPOSOMES - A COMPARISON WITH THE INTRAVENOUS AND INTRAPERITONEAL ROUTES OF INJECTION [J].
ALLEN, TM ;
HANSEN, CB ;
GUO, LSS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1150 (01) :9-16
[2]
RECOGNITION OF CHARGED LIPOSOMES BY RAT PERITONEAL AND SPLENIC MACROPHAGES - EFFECTS OF FIBRONECTIN ON THE UPTAKE OF CHARGED LIPOSOMES [J].
ARAMAKI, Y ;
AKIYAMA, K ;
HARA, T ;
TSUCHIYA, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 3 (02) :63-70
[3]
TESTING FOR THE EQUALITY OF AREA UNDER THE CURVES WHEN USING DESTRUCTIVE MEASUREMENT TECHNIQUES [J].
BAILER, AJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1988, 16 (03) :303-309
[4]
CARR I., 1973, MACROPHAGE REV ULTRA
[5]
Biodistribution, pharmacokinetics and imaging of 188Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model [J].
Chen, Liang-Cheng ;
Chang, Chih-Hsien ;
Yu, Chia-Yu ;
Chang, Ya-Jane ;
Hsu, Wei-Chuan ;
Ho, Chung-Li ;
Yeh, Chung-Hsin ;
Luo, Tsai-Yueh ;
Lee, Te-Wei ;
Ting, Gann .
NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (04) :415-423
[6]
DAOUD SS, 1994, CANCER CHEMOTH PHARM, V33, P307
[7]
Intraperitoneal chemotherapy for colorectal cancer [J].
De Bree, E ;
Witkamp, AJ ;
Zoetmulder, FAN .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (01) :46-61
[8]
Drummond DC, 1999, PHARMACOL REV, V51, P691
[9]
A DISTRIBUTED MODEL OF PERITONEAL-PLASMA TRANSPORT - THEORETICAL CONSIDERATIONS [J].
FLESSNER, MF ;
DEDRICK, RL ;
SCHULTZ, JS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (04) :R597-R607
[10]
Gad SC, 1992, ANIMAL MODELS TOXICO